Pre-exposure (PrEP)
Pre-exposure Prophylaxis (PrEP)
AIDS 2014: iPrEx OLE Shows PrEP Effectiveness Is 100% for Those Taking 4 or More Doses per Week
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 22 July 2014 00:00
- Written by Gus Cairns
iPrEx OLE, the open-label extension of the iPrEx study of pre-exposure prophylaxis (PrEP), reported its main findings this week at the 20th International AIDS Conference in Melbourne, Australia, published simultaneously in The Lancet Infectious Diseases. Overall PrEP effectiveness was 50% overall, but 100% in those taking 4 or more doses per week. There was a substantial early drop-out rate, especially among young people.
WHO Recommends Pre-Exposure Prophylaxis for Men Who Have Sex with Men
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Wednesday, 16 July 2014 00:00
- Written by Liz Highleyman
Gay and bisexual men who are at risk for HIV infection should consider using antiretroviral drugs for pre-exposure prophylaxis (PrEP), according to new guidelines from the World Health Organization (WHO), part of a set of recommendations for key populations affected by the HIV/AIDS epidemic.
San Francisco HIV Forum Asks: Is Undetectable the New Negative?
- Details
- Category: Treatment as Prevention
- Published on Friday, 23 May 2014 00:00
- Written by Liz Highleyman
More than 100 participants packed the Eureka Valley Recreation Center in San Francisco on May 20 for the latest Real Talk discussion of new HIV prevention strategies including pre-exposure prophylaxis (PrEP) and antiretroviral treatment as prevention.
New Studies Offer More Insight on HIV Sexual Transmission and Prevention
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Wednesday, 04 June 2014 00:00
- Written by Liz Highleyman
A new estimate puts the likelihood of HIV transmission via receptive anal sex at 138 per 10,000 acts, but looking at probabilities over a longer period provides a better understanding of risk than per-act probabilities, according to a pair of studies in the May 6 advance online edition of AIDS. Mathematical models showed that combining prevention methods -- especially those that include antiretroviral treatment-as-prevention or PrEP -- can greatly reduce the risk of transmission.
New CDC Guidelines: People at Risk for HIV Should Consider Truvada PrEP
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Wednesday, 14 May 2014 00:00
- Written by Liz Highleyman
Healthcare providers should advise people at "substantial risk" for HIV infection about pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine, or Truvada, according to new guidelines issued by the U.S. Centers for Disease Control and Prevention (CDC). This includes HIV negative people in an ongoing sexual relationship with HIV positive partners, gay or bisexual men who have had sex without condoms during the past 6 months, heterosexual men and women who have sex without condoms with at-risk partners, and injection drug users.
Web Design and Development by